Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Toxicon : Official Journal of the International Society on Toxinology|April 5, 2020
Health risk assessment related to pinnatoxins in French shellfishNathalie Arnich, Eric Abadie, Nicolas Delcourt, et al.Elife|June 12, 2026
Starvation of the bacterium Vibrio atlanticus induces simultaneous attacks on the dinoflagellate Alexandrium pacificumJean-Luc Rolland, Estelle Masseret, Mohamed Laabir, et al.Toxicon : Official Journal of the International Society on Toxinology|September 17, 2022
Development of harmful algal blooms species responsible for lipophilic and amnesic shellfish poisoning intoxications in southwestern Mediterranean coastal watersHicham Aboualaalaa, Mohammed L'Bachir El Kbiach, Benlahcen Rijal Leblad, et al.Current Medical Research and Opinion|March 11, 2015
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritisJean-Yves Reginster, Cyrus Cooper, Marc Hochberg, et al.European Heart Journal|March 17, 2012
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?Faiez Zannad, Wendy Gattis Stough, Stuart J Pocock, et al.Osteoarthritis and Cartilage|March 17, 2004
Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritisEric Abadie, Dominique Ethgen, Bernard Avouac, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.Bone|June 12, 2008
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosisJörg Goldhahn, Wim H Scheele, Bruce H Mitlak, et al.BMJ Open|September 3, 2014
Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeAurélie Delzor, Philippe Couratier, Farid Boumédiène, et al.Drugs & Aging|June 19, 2015
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and FrailtyNigel Arden, Pascal Richette, Cyrus Cooper, et al.Pageof 7